Andrea Adamo, Ph.D. - Founder and CEO
Dr. Andrea Adamo is an entrepreneur with extensive experience in the development of innovative engineering solutions and the developer of Zaiput core technologies. He also serves as the Innovation Advisor at Snapdragon Chemistry. Dr. Adamo holds a Master of Science in Engineering from the University of Palermo, Italy and a Ph.D. in Fluid Mechanics from the University Federico II of Naples, Italy in addition to a Master of Science from the Massachusetts Institute of Technology. He was also awarded the Fulbright Scholarship. After completing his graduate studies, Dr Adamo joined the laboratory of Professor Klavs Jensen, Director of the MIT Chemical Engineering Department and arguably one the world leaders in continuous flow chemistry. He worked in the Jensen Group first as a post doctoral associate and than as a research associate. In these positions, Dr. Adamo gained extensive experience in the design and manufacturing of innovative microfluidic and millifluidic systems.
Jennifer Baltz, Ph.D. - Co-Founder and COO
Jennifer Baltz, Ph.D. is a scientist with expertise in fields ranging from biophysics to basic biology and an entrepreneur with extensive business experience. Dr Baltz holds a Bachelor of Science from Johns Hopkins University and a Ph.D. in Biochemistry from Harvard University. She has been involved in the fundraising, boot-strapping and operation of several start up companies at different levels. She has been collaborating for several years with one of the largest angel investment groups in the US and with multiple investment funds focused on innovative technologies. She brings to Zaiput a breadth of business expertise, scientific acumen and connections in the business arena and is currently coordinating Zaiput's financial and business strategy.
Timothy F. Jamison, Ph.D.
Dr. Jamison is a Full Professor in the Department of Chemistry at the Massachusetts Institute of Technology (MIT) and a Co-Founder and Scientific Advisor of Snapdragon Chemistry. He received his Bachelor’s degree from the University of California, Berkeley, and his Ph.D. from Harvard University. Professor Jamison has received of numerous honors and awards in recognition of his research contributions, including the American Chemical Society Arthur C. Cope Scholar Award, the JSPS Invitation Fellowship, the Sloan Research Fellowship, the GlaxoSmithKline Scholar Award, the Amgen Young Investigator Award, the Boehringer Ingelheim New Investigator Award, National Science Foundation CAREER Award, and the 3M Innovation Award. In addition to this, Professor Jamison serves on the International Advisory Board for the Journal of Flow Chemistry and on the Academic Advisory Board for Advanced Synthesis and Catalysis. The research in Professor Jamison's group focuses on discovering and developing new methods for synthesizing organic molecules. Professor Jamison has published over 100 research articles and 15 patents.
Roger Dowd is a CEO and entrepreneur with more than twenty years of product and business development experience in the laser scanning, life science and medical industries. Starting in 1985, Mr. Dowd held several positions at General Scanning Inc. (GSI) including General Manager of the Life Sciences Business Unit. In that position, he led the transformation of an advanced engineering team into a life sciences business, culminating in its sale to Packard BioSciences for $120M. After the sale of the life sciences business, Mr. Dowd was recruited to lead the GSI Lumonics memory repair product line, a position that he left in December of 2001. In 2002 he co-founded Decision Biomarkers a protein biomarker platform company. Mr. Dowd holds a B.S. in Electrical Engineering from Northeastern University and is named inventor on seven issued patents.
Davide Marini, Ph.D.
Davide Marini is a technology entrepreneur, focusing on opportunities in life sciences, medical devices, clinical diagnostics and software. He is currently the Co-Founder and CEO at inkbit. He previously served as the Managing Director at Abcam and before that as the CEO of Firefly BioWorks (acquired by Abcam), a company commercializing an innovative platform for multiplexed detection of biomarkers. Prior to Firefly, he was a research fellow in the Department of Cardiology at Children's Hospital Boston, where he worked on nanotechnology approaches to detecting the activity of ion channels. Davide received his Ph.D. in the Department of Mechanical Engineering at MIT, an M.B.A. from Collège des Ingénieurs (Paris, France) and a B.S. in Industrial Engineering from Politecnico of Milan (Italy).
Antonino Vaccaro, Ph.D.
Antonino Vaccaro is the Academic Director and a full time professor at the Center for Business in Society of the IESE Business School (Spain). His scientific and professional interests concern the intersection between technology strategy and organizational responsibility and accountability. Before joining IESE, Antonino has served as Executive Director of the Center for Ethics, Business and Economics of the Lisbon-Catolica, as research fellow in the Department of Engineering and Public Policy of Carnegie Mellon University and in the Information Ethics Group of the University of Oxford. Antonino Vaccaro has worked in consultancy and applied research projects for a number of companies including Southern Company, Artsana Group, Tecnotre, the Portuguese Judiciary Police, the UN Global Compact, EDP Foundation, Volkswagen, and REWE. Professor Vaccaro has also consulted as an expert in international dispute resolutions related to product liability, damage claims and asset evaluation. Antonino Vaccaro’s publications have appeared in journals including Research Policy, Journal of Management Studies, Journal of Business Ethics, Ethics and Information Technology, The Information Society and Technological Forecasting and Social Change.